A groundbreaking study reveals that a single dose of psilocybin, the active compound in magic mushrooms, can provide ...

In a phase 2 trial, about half of cancer patients reported sustained reductions in depression and anxiety 2 years after a ...

Half a decade after receiving a psychedelic treatment for depression, two-thirds of patients in a new study remained in ...

Psilocybin, the active ingredient in magic mushrooms, might just revolutionize how depression and anxiety are treated in ...

About half of patients had sustained reduction in depression and anxiety up to two years after psilocybin and psychotherapy.

New research shows a single dose leads to 'robust' reductions in depression and anxiety up to 2 years afterward.

A pilot study involving psilocybin-assisted therapy found possible antidepressant effects for people with bipolar II disorder ...

New results from a clinical trial reveal that a single dose of psilocybin—a naturally occurring psychedelic compound found in ...

The psilocybin found in "magic mushrooms" might be key to quelling depression among people battling cancer, a new study found ...

New Zealand has approved the restricted medicinal use of psilocybin, a hallucinogen found in “magic mushrooms” for patients ...

Psilocybin, a psychedelic compound once primarily known as a party drug, is increasingly being recognised for its medical ...